CONTINUING EDUCATION

Pre-diabetes and type 2 diabetes management

With 25.8 million Americans diagnosed with diabetes and an estimated 79 million more pre-diabetic, every pharmacist must be able to counsel patients and monitor progression. Earn up to 2 CPE credits. » Click here to login and take the exams.

LEGAL NEWS

FDA appeals U.S. District Court ruling on pharmacy compounding

FDA has appealed the September 2011 ruling made by the U.S. District Court for the Middle District of Florida in U.S. v. Franck’s Lab, Inc. The ruling had favored pharmacy compounding for veterinary patients. » More

CLINICAL NEWS

More stroke patients going home on anticoagulants

As many as 95% of stroke patients with atrial fibrillation received prescriptions for anticoagulants in 2010 if they were treated at hospitals that participate in the "Get With The Guidelines – Stroke" program, researchers found, which is up from 88% in 2003. » More

AHA, ACC release updated guidelines on secondary prevention of atherosclerotic vascular disease

The American Heart Association and American College of Cardiology Foundation have issued new guidelines for secondary prevention and risk reduction in patients with atherosclerotic vascular disease. » More

Survey

President Obama’s executive order to take action on the public health crisis of prescription drug shortages includes directing FDA to broaden reporting of potential shortages, expedite regulatory reviews, and increase staffing resources for the FDA’s Drug Shortages Program. Do you agree with his executive order?

a) Yes, it will definitely make a difference to the prescription drug shortages.
b) Yes, but it will take more than the order to fix the prescription drug shortages.
c) No, Congress should be enacting legislation to fix the prescription drug shortages.
d) No, the order will do little to help the prescription drug shortages.

Respond here and see what your colleagues think too.

Want to see the results of our last survey about the implications of the possible Express Scripts/Medco merger? Click here.

FDA ACTIONS

FDA revokes breast cancer indication for bevacizumab

FDA Commissioner Margaret A. Hamburg, MD, announced the agency's decision to revoke the breast cancer indication for bevacizumab (Avastin), noting that the benefits do not outweigh the potentially life-threatening side effects. » More

FDA approves aflibercept to treat wet AMD

Regeneron Pharmaceuticals said U.S. regulators approved its new drug aflibercept (Eylea) for treating wet age-related macular degeneration, which affects at least 1.5 million Americans. » More

Alimera receives CRL from FDA for intravitreal insert

FDA has issued a complete response letter to the New Drug Application for the extended-release intravitreal insert (Iluvien, Alimira Sciences) for the treatment of diabetic macular edema associated with diabetic retinopathy. » More

FDA approves first drug to treat a rare bone marrow disease

FDA has approved ruxolitinib (Jakafi, Incyte) for the treatment of patients with intermediate or high-risk myelofibrosis. » More

Confirm your
e-newsletter subscription click here.

To ensure future delivery of email newsletters from Drug Topics please take a moment to confirm your subscription by clicking here.
Thank you,
Drug Topics Staff

Voices

Digital Edition